Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -14.609% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
[a] COc1ccc2[nH]c3c(NCCCN4CCCC4=O)ncnc3c2c1
[b] N#CC(C#N)=C(N)/C(C#N)=C/c1cc(O)c(O)c(O)c1
[c] CC(=O)Nc1cccc(NC(=O)c2cc(C)on2)c1
Answer: a. COc1ccc2[nH]c3c(NCCCN4CCCC4=O)ncnc3c2c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc2[nH]c3c(NCCCN4CCCC4=O)ncnc3c2c1
COc1ccc2[nH]c3c(NCCCN4CCCC4=O)ncnc3c2c1
1-[3-[(8-methoxy-5H-pyrimido[5,4-b]indol-4-yl)amino]propyl]pyrrolidin-2-one